Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7088)
All Articles published online
|
Publishing Process of This Article
|
Dec 22, 2016 (publication date) through May 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Olsen RE, Kroken RA, Bjørhovde S, Aanesen K, Jørgensen HA, Løberg EM, Johnsen E. Influence of different second generation antipsychotics on the QTc interval: A pragmatic study. World J Psychiatr 2016; 6(4): 442-448 [PMID: 28078208 DOI: 10.5498/wjp.v6.i4.442] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v6/i4/442.htm |
| Number | Citing Articles |
| 1 |
Luyao He, Yimin Yu, Lei Zhang, Shen He, Wenjuan Yu, Lujin Li, Jingjing Huang, Huafang Li. A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics. Journal of Clinical Psychopharmacology 2022; 42(1): 71 doi: 10.1097/JCP.0000000000001501
|
| 2 |
Lei Sun, Sergey Yagoda, Hongqi Xue, Randy Brown, Narinder Nangia, David McDonnell, Bhaskar Rege, Lisa von Moltke, Borje Darpo. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020; 100: 109881 doi: 10.1016/j.pnpbp.2020.109881
|
| 3 |
Tomoyuki Takano. Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability. Cureus 2023; doi: 10.7759/cureus.48088
|
| 4 |
Wei Du, Meng-Wei Ge, Fei-Hong Hu, Yi-Jie Jia, Dan-Yan Zhao, Yu-Jie Cheng, Hong-Lin Chen. QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors. Journal of Psychopharmacology 2023; 37(10): 971 doi: 10.1177/02698811231190864
|
| 5 |
Xiao-Qing Li, Xin-Ru Tang, Li-Liang Li. Antipsychotics cardiotoxicity: What's known and what's next. World Journal of Psychiatry 2021; 11(10): 736-753 doi: 10.5498/wjp.v11.i10.736
|
| 6 |
Yasar Torres-Yaghi, Amelia Carwin, Jacob Carolan, Steven Nakano, Fahd Amjad, Fernando Pagan. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review. Neuropsychiatric Disease and Treatment 2021; : 3791 doi: 10.2147/NDT.S324145
|
| 7 |
Annemarie Unger, Thomas Foki, Gabriele Sachs. Einsatz von Antipsychotika bei Parkinson-Psychose und Multimorbidität. psychopraxis. neuropraxis 2017; 20(5): 203 doi: 10.1007/s00739-017-0420-8
|
| 8 |
Shagun Krishna, Alexandre Borrel, Ruili Huang, Jinghua Zhao, Menghang Xia, Nicole Kleinstreuer. High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition. Biology 2022; 11(2): 209 doi: 10.3390/biology11020209
|
| 9 |
Pierre S. Chue, Arno G. Siraki. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2017; 39: 65 doi: 10.1016/bs.seda.2017.06.029
|
| 10 |
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti, Massimo Di Giannantonio. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic Advances in Drug Safety 2018; 9(5): 237 doi: 10.1177/2042098618756261
|